Actionable news
0
All posts from Actionable news
Actionable news in PTCT: PTC Therapeutics, Inc.,

Forget Sarepta Therapeutics, This DMD Stock Could Be A Better Buy

Key Statistics

Market Cap233M
P/E Ratio (ttm)-1.32
Diluted EPS-5.14
Beta0.83
Earnings DateAug 4, 2016
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.00

Million $

Strong Buy
Buy
Hold
Underperform
Sell
DowngradeWedbush: Outperform to Neutral3/1/2016
DowngradeBofA/Merrill: Buy to Neutral2/29/2016
DowngradeCitigroup: Buy to Neutral2/24/2016
DowngradeRBC Capital Mkts: Outperform to Sector Perform2/24/2016
UpgradeJefferies: Underperform to Hold2/24/2016
DowngradeJP Morgan: Overweight to Neutral2/23/2016

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery...


More